Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPL | P06858 | 7/20 | 0.88 |
| ▸ | LIPG | Q9Y5X9 | 7/20 | 0.88 |
| ▸ | CA2 | P00918 | 3/20 | 0.68 |
| ▸ | CA1 | P00915 | 2/20 | 0.68 |
| ▸ | TRPV1 | Q8NER1 | 3/20 | 0.63 |
| ▸ | MGLL | Q99685 | 2/20 | 0.63 |
| ▸ | F11 | P03951 | 1/20 | 0.47 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.45 |
| ▸ | CNR1 | P21554 | 1/20 | 0.44 |
| ▸ | CNR2 | P34972 | 1/20 | 0.44 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.42 |
| ▸ | RARB | P10826 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL257735 | 0.94 | LPL (1.00) | LPLLIPGCA2CA1TRPV1 | |
| SCHEMBL13454827 | 0.88 | CA1 (0.89) | LPLLIPGCA2CA1TRPV1 | |
| SCHEMBL1791067 | 0.86 | LPL (0.89) | LPLLIPGCA2CA1TRPV1 | |
| Methyl Alcohol SCHEMBL28643312 | 0.85 | LPL (0.86) | LPLLIPGCA2CA1TRPV1 | |
| SCHEMBL15087090 | 0.85 | LPL (0.89) | LPLLIPGCA2CA1TRPV1 | |
| SCHEMBL7111292 | 0.85 | LPL (0.89) | LPLLIPGCA2CA1TRPV1 | |
| SCHEMBL7474712 | 0.84 | LPL (0.81) | LPLLIPGCA2CA1TRPV1 | |
| SCHEMBL2482085 | 0.83 | LPL (0.86) | LPLLIPGCA2CA1TRPV1 | |
| SCHEMBL29167102 | 0.82 | LPL (0.78) | LPLLIPGCA2CA1TRPV1 | |
| SCHEMBL4802707 | 0.82 | LPL (0.54) | LPLLIPGCA2MGLLMCL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112470045-B | Optical filter and display device | 住友化学株式会社 | 2023-08-08 | — | — | CN | disclosed |
| CN-111051473-B | Liquid crystal composition and liquid crystal display element | 捷恩智株式会社 | 2023-08-01 | — | — | CN | disclosed |
| CN-111148769-B | Liquid crystal composition, phase difference film and method for producing same, transfer laminate, optical member and method for producing same, and display device | 大日本印刷株式会社 | 2023-01-10 | — | — | CN | disclosed |
| US-20220340893-A1 | BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | NUEVOLUTION A/S (DK) | 2022-10-27 | — | — | US | disclosed |
| US-20190284475-A1 | LIQUID CRYSTAL COMPOUND AND A LIQUID CRYSTAL COMPOSITION INCLUDING THE SAME | DAXIN MATERIALS CORP. (TW) | 2019-09-19 | — | — | US | disclosed |
| US-10221114-B2 | Liquid crystal compound having tetrafluoro cyclohexadiene structure showing negative anisotropy, liquid crystal composition, and liquid crystal display device | JNC CORPORATION (JP) | 2019-03-05 | — | — | US | disclosed |
| CN-105838385-B | Liquid crystal compound, liquid crystal composition containing same, electro-optical display and liquid crystal display device | 达兴材料股份有限公司 | 2019-01-29 | — | — | CN | disclosed |
| US-10113116-B2 | Liquid crystal compound and liquid crystal composition employing the same | DAXIN MATERIALS CORPORATION (TW) | 2018-10-30 | — | — | US | disclosed |
| US-20180094191-A1 | LIQUID CRYSTAL COMPOUND CONTAINING 2,3,4-TRISUBSTITUTED BENZENE AND COMPOSITION THEREOF | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIALS CO LTD (CN) | 2018-04-05 | — | — | US | disclosed |
| US-9822301-B2 | Alkenyl ether compound and a liquid crystal composition using the same | DIC CORPORATION (JP) | 2017-11-21 | — | — | US | disclosed |
| US-20090099131-A1 | INHIBITORS OF FATTY ACID AMIDE HYDROLASE | INFINITY DISCOVERY, INC. (US) | 2009-04-16 | — | — | US | disclosed |
| US-20090099131-A1 | INHIBITORS OF FATTY ACID AMIDE HYDROLASE | INFINITY DISCOVERY, INC. (US) | 2009-04-16 | — | — | US | disclosed |
| WO-2008063300-A2 | BORONIC ACIDS AND ESTERS AS INHIBITORS OF FATTY ACID AMIDE HYDROLASE | INFINITY PHARMACEUTICALS, INC. (US) | 2008-05-29 | — | — | WO | disclosed |
| EP-1644460-B1 | SUBSTITUTED ANTHRACENES | MERCK PATENT GMBH (DE) | 2008-01-30 | — | — | EP | disclosed |
| US-20070014934-A1 | Substituted anthracenes | MERCK PATENT GMBH (DE) | 2007-01-18 | — | — | US | disclosed |
| EP-1223209-B1 | Fluorinated fluorenes and use thereof in liquid crystal mixtures | CLARIANT INT LTD (CH) | 2004-03-03 | — | — | EP | disclosed |
| EP-1223209-A1 | Fluorinated fluorenes and use thereof in liquid crystal mixtures | CLARIANT INTERNATIONAL LTD. (CH) | 2002-07-17 | — | — | EP | disclosed |
| US-5637257-A | LIQUID CRYSTAL DISPLAYING | MERCK PATENT GESELLSCHAFT MLT BESCHRANKTER HAFTUNG (DE) | 1997-06-10 | — | — | US | disclosed |
| US-5482653-A | FOR LIQUID CRYSTAL DISPLAY | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1996-01-09 | — | — | US | disclosed |
| EP-0428666-B1 | FLUORO-CHLORO-BENZENE DERIVATIVES | MERCK PATENT GMBH (DE) | 1995-03-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10113116-B2 | Liquid crystal compound and liquid crystal composition employing the same | ZYX, MLX, NPM1 | LPL 993/4885LIPG 2470/4885CA2 2293/4885 |
| US-20090099131-A1 | INHIBITORS OF FATTY ACID AMIDE HYDROLASE | FAAH, FAAH2, ASAH1 | LPL 180/4885LIPG 272/4885CA2 1331/4885 |
| US-10221114-B2 | Liquid crystal compound having tetrafluoro cyclohexadiene structure showing negative anisotropy, liquid crystal composition, and liquid crystal display device | OCIAD2, CNOT1, OCIAD1 | LPL 3538/4885LIPG 3807/4885CA2 952/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.